UNDERSTANDING MULTIPLE SCLEROSIS
Multiple sclerosis (MS) is an unpredictable, often disabling disease of the central nervous system (CNS) that disrupts the flow of information within the brain, and between the brain and body. According to the National Multiple Sclerosis Society, the disease is thought to affect more than 2.3 million people worldwide, that number may be a significant under estimate since MS is not a reportable disease and no centralized reporting system exists at this time. Also, MS can be difficult to diagnose. Since there is no single test for MS, the diagnosis can be missed, delayed or even incorrect.
In MS, the immune system malfunctions destroying the myelin which is the fatty substance that coats and protects nerve fibers in the brain and spinal cord. Often times, the myelin is compared to the insulation coating that surrounds electrical wires. When the surrounding protective myelin is damaged and the nerve fibers are exposed, the messages traveling along the nerve become slow or potentially blocked. In some cases, the nerve becomes damaged.
Adult stem cells are potentially the most diverse and effective healing agents ever known and have been proven to treat an astounding variety of conditions, ranging from injuries to chronic, debilitating diseases. Over million adult stem cell treatments and counting have been perform and many have improved health and quality of life for patients with unmet clinical needs.
Groundbreaking research related to adult stem cell therapy for slowing MS disease and for repairing damage to the nervous system has shown much progress. At StemGenex Medical Group, our staff has personally witnessed how the use of adipose-derived stem cells (from fat tissue) have improved the quality of life of many patients seen for Multiple Sclerosis. Weve felt inspired by how these patients have responded to StemGenexs integrated healthcare approach to treating MS.
Stem cells are highly potent healing agents in the body and have shown therapeutic effects through a wide range of modalities. We frequently hear from patients who are extremely grateful for the relief and improved quality of life they have experienced following stem cell therapy for Multiple Sclerosis.
In any type of treatments for MS, it is essential to address the underlying cause of autoimmunity through modulating the immune system in addition to repairing damaged neurological tissue.The primary causes contributing to the progression of Multiple Sclerosis is due to the bodys autoimmune attack against the central nervous system causing damage to the nerve fibers and their protective myelin sheath, resulting in demyelination. Groundbreaking research indicates adipose-derived stem cells have the potential to address these two main causes that contribute to the progression of Multiple Sclerosis by inhibiting the immune attack against the central nervous system and stimulating regeneration damaged tissue in the body. Adipose-derived stem cell treatment has the ability to address both fundamental causes of the disease by selectively homing to areas in the body of damaged tissue and repair function and healing.
According to research, adipose-derived stem cells have the potential to be excellent candidates for Multiple Sclerosis for two main reasons:
Woman Battling Multiple Sclerosis Sees Improvements from Stem Cell Therapy
We often hear from patients who are extremely grateful for the relief they have experienced following adipose-derived stem cell treatment. Patients have reported the following improved quality of life benefits associated with Multiple Sclerosis:
Through customized, targeted stem cell treatment plans, our goal is to offer patients access to adult stem cell treatment that has the potential to significantly improve ones quality of life. Stem cell therapy consists of a very simple and brief liposuction procedure where the patients adipose (fat) tissue is extracted from patients body in our AAAHC accredited surgical center by accomplished board certified physicians. Through our proprietary protocols, the adipose tissue is then processed by laboratory technicians in our on-site state-of-the-art laboratory. The stem cells are then comfortably infused back into the patients body, which takes place in a comprehensive one-day outpatient procedure in our distinguished stem cell treatment facility.
Currently, Multiple Sclerosis medications only offer treatment and therapy for the symptoms of the disease. These drugs may help with symptoms, but only at the expense of serious, often life-endangering side effects.
Unfortunately, there is no standard medical treatment for the two main causes that contribute to the progression of the disease which include the bodys autoimmune attack against the central nervous system, and the resulting demyelination. Majority of MS drugs focus on addressing symptoms for only one of the primary causes of progression. Current MS drugs are designed to suppress, alter, or slow down the activity of the bodys immune system; however, these drugs do not address the regeneration of the lost myelin.
Stem cell therapy has been shown to help both primary causes of the disease progression by repairing and regenerating damaged tissue, modulating the immune system and slowing down inflammation. In the near future, it is anticipated that stem cell treatment will potentially surpass conventional drug therapy.
Adipose-derived stem cells, also known as mesenchymal stem cells (MSCs) have shown therapeutic benefits for treating Multiple Sclerosis. Adult mesenchymal stem cells are found in several places throughout the body including adipose tissue, also known as your fat tissue. Adipose tissue includes a variety of cell types which includes the stromal-vascular fraction (SVF). The SVF contains an abundant amount of stem cells called adipose-derived stem cells and also contains high concentrations of other very beneficial components (T-regulatory cells, preadipocytes, endothelial precursor cells, anti-inflammatory macrophage) with robust anti-inflammatory and immunomodulatory properties.
Known to be very potent, adipose-derived stem cells have the capacity to differentiate into various specialized cells in our body. They have the unique ability to produce additional cells which help other stem cells function properly and have the ability to selectively hone into areas in the body of injured tissue and repair functionality.
Committed to the science and innovation of stem cell treatment, StemGenex sponsors a clinical study registered with the National Institutes of Health (NIH) for Multiple Sclerosis. The study Outcomes of Data of Adipose Stem Cells to Treat Multiple Sclerosis has been established to formally document and evaluate the quality of life changes in individuals following adipose-derived stem cell treatment.
If you are interested in learning more about the Outcomes of Data of Adipose Stem Cells to Treat Multiple Sclerosis clinical study, contact a StemGenex Medical Group Patient Advocate at 800-974-1335 or Click Here to provide your contact information.
Recommendation and review posted by Guinevere Smith